Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Energy Balance and Breast Cancer Aspects-II Study

NCT02240836 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02240836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02240836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Energy Balance and Breast Cancer Aspects-II Study
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2014
Completion date
October 31, 2027
Enrollment
545 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dcis grade 3, lcis, lobular carcinoma in situ, stage i breast cancer, stage ii breast cancer